Document is current
Any future updates will be listed below
-
Authors
Charneca, Sofia
Hernando, Ana
Almada-Correia, Inês
Polido-Pereira, Joaquim
Vieira, Adriana
Sousa, Joana
Almeida, Ana Santos
Motta, Carla
Barreto, Gonçalo
Eklund, Kari K.
Alonso-Pérez, Ana
Gómez, Rodolfo
Cicci, Francesco
Mauro, Daniele
Pinho, Salomé S.
Fonseca, João Eurico
Costa-Reis, Patrícia
Guerreiro, Catarina Sousa
-
Funding
Funding for this research was provided by:
European Union's Horizon Europe research and innovation programme (101095084, 101095084, 101095084, 101095084, 101095084)
University of Helsinki
- License Information
-
More Information
Article History
Received: 8 December 2024
Accepted: 6 February 2025
First Online: 7 April 2025
Declarations
:
: This trial was approved by the ethics committee of Lisbon Academic Medical Centre, CAML (Ref. Nº114/22). The ethical norms and standard conduct rules specified in the Helsinki Declaration as modified and its later amendments, or comparable ethical standards, will be followed and respected. Participants sign a written informed consent form before any study procedures. All biologic samples will be coded and stored at the Biobank-GIMM, ensuring their safety and protection. Biobank-GIMM was approved by the ethics committee of CAML and by the National Data Protection Board [].
: Not applicable.
: The authors declare no competing interests.
